STAT3 and neoplasm: Therefore, silibinin offers significant promise as a therapeutic agent in reversing tumor drug resistance through various mechanisms, including inhibition of drug efflux pumps, modulation of cell adhesion, and regulation of key signaling pathways like STAT3.